Trials / Active Not Recruiting
Active Not RecruitingNCT06728124
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects
A Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 630 (estimated)
- Sponsor
- Gan & Lee Pharmaceuticals. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study in adult obese/overweight subjects in China to evaluate the efficacy and safety of GZR18 Injection in the subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GZR18 | Used as specified in the protocol |
| OTHER | Placebo | Administered the same volume as GZR18 |
Timeline
- Start date
- 2024-12-30
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2024-12-11
- Last updated
- 2025-11-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06728124. Inclusion in this directory is not an endorsement.